title: T cell allorecognition and endogenous HLA-B27-bound peptides in a cell line with defective HLA-B27-restricted antigen presentation.
abstract: The B*2702+ lymphoblastoid cell line NW is unable to present at least some HLA-B27-restricted viral antigens to T cells. This defect was genetically inherited, and was suggested to be related to the nature of the HLA-B27 binding peptides reaching the endoplasmic reticulum in these cells (Pazmany et al., J. Exp. Med. 1992. 175: 361). In the present study 17 of 19 HLA-B27-specific alloreactive cytotoxic T lymphocyte clones recognizing the B*2702 subtype on other cells also lysed NW cells. Only two cytotoxic T lymphocyte clones failed to lyse NW while efficiently killing other B*2702+ cell lines. The high-performance liquid chromatography profiles of the B*2702+ bound peptides extracted from NW cells was similar, but not identical, to those from two other cell lines. These results indicate that the HLA-B27-bound peptide repertoire in NW cells is not fundamentally different from those in other B*2702+ cells. Our data argue against gross differences in peptide processing or transport as being responsible for the defective presentation of particular HLA-B27-restricted viral antigens to T cells, but do not rule out distinct presentation of some endogenous peptides. Differences in the capacity to present certain peptides could cause differential susceptibility among HLA-B27+ individuals to ankylosing spondylitis.
authors.affiliation: Centro de Biología Molecular, Severo Ochoa, Universidad Autónoma de Madrid, Cantoblanco, Spain.
authors.forename: D
authors.initials: D
authors.lastname: López
authors.forename: R
authors.initials: R
authors.lastname: García-Hoyo
authors.forename: F
authors.initials: F
authors.lastname: García
authors.forename: J A
authors.initials: JA
authors.lastname: López de Castro
mesh_terms: D000911:Antibodies, Monoclonal; D000938:Antigen-Presenting Cells / Q000276:immunology*; D002460:Cell Line; D002469:Cell Separation; D002851:Chromatography, High Pressure Liquid; D003602:Cytotoxicity, Immunologic / Q000502:physiology; D005434:Flow Cytometry; D015796:HLA-B27 Antigen / Q000502:physiology*; D006801:Humans; D010455:Peptides / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D015796:HLA-B27 Antigen; D010455:Peptides